Program at a Glance
8:00 a.m. - 8:40 a.m. Registration, Continental Breakfast
8:45 a.m. - 8:55 a.m. Opening
9:00 a.m. - 11:50 a.m. Concurrent Workshops
|9:00 a.m. - 9:50 a.m.
|10:00 a.m. - 10:50 a.m.
|11:00 a.m. - 11:50 a.m.
|1A: Tax Cuts and Jobs Act 2018: What You Need to Know?||2A: Everyone is interesting ... to Cyber Criminals||3A: The Pocket-Sized Video Production Studio: Your Smart Phone|
|1B: Becoming an Entrepreneur. It's Not Easy, but It's Worth It||2B: The Pocket-Sized Video Production Studio: Your Smart Phone||3B: Using Canva to Build Your Brand|
|1C: How to Start Small and Grow Big on Social Media||2C: Epicenter: What Can It Do For You||3C: Workplace Situational Awareness|
|1D: Guess What Happened to Me? Customer Service Tips for Business||2D: Why Don't People Buy My Stuff?||3D: The Funding Continuum: Something for (Almost) Everybody|
|1E: The Pocket-Sized Video Production Studio: Your Smart Phone||2E: Employee Engagement: What You Know FOr Sure That Just Ain't SO||3E Modern Marketing for the Social Media Savvy|
12:00 p.m. - 12:30 p.m. Lunch/ Acknowledgments
12:30 p.m. - 1:30 p.m. Keynote Address: Robert Metz: Sr. Vice President Global Business Operations and External Affairs at Horizon Pharma
1:30 p.m. - 3:00 p.m. Resource Fair & Networking
3:00 p.m. - 4:30 p.m. Entrepreneur of the Year Award/PioPitch/Closing
Robert W. Metz
Senior Vice President, Business Operations and External Affairs, Horizon Pharma
Mr. Metz joined Horizon Pharma in 2009 as the vice president global business operations and general manager Europe. He is responsible for the administration of global business operations and corporate external affairs. Mr. Metz has over 28 years of commercial, external affairs, finance, project management, HR and IT administration, business development and operations experience in both small and large pharmaceutical and biotechnology organizations. Prior to joining Horizon Pharma, Mr. Metz’s most recent position was vice president, commercial operations for IDM Pharma who manufactured MEPACT® for pediatric osteosarcoma, an ultra-orphan pediatric cancer. Mr. Metz played a key role in the turnaround and eventual sale of IDM Pharma to Takeda Pharmaceuticals in June 2009. Prior to joining IDM Pharma, Mr. Metz led commercial operations for NeoPharm, a publically traded rare disease oncology biotechnology company with a phase 3 compound for glioblastoma multiforme. For nearly 13 years, Mr. Metz worked in areas of increasing responsibility at Searle, Pharmacia and Pfizer focusing on product introductions on several products, including Celebrex®, Arthrotec®, Daypro® and Detrol LA®. In his commercial management roles, Mr. Metz directed multifunctional, operational and performance aspects of sales organizations spanning over 650 sales and support employees with overall sales totaling over $2 billion. Mr. Metz has a bachelor’s degree in management/economics from Marietta College.